TG Therapeutics, Inc.
S&P 600
$53.89
-2.71%
Delayed · cached 15 min
Frequently asked questions
What sector does TG Therapeutics, Inc. belong to?
TG Therapeutics, Inc. operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of TGTX?
As of the latest available quote, TGTX traded at $53.89. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of TGTX?
TG Therapeutics, Inc. has a price-to-earnings (P/E) ratio of about 19.67. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of TGTX?
The market capitalisation of TG Therapeutics, Inc. is approximately $8.70B.
Is TG Therapeutics, Inc. profitable?
For its latest reported financial year, TG Therapeutics, Inc. recorded a net profit margin of about 72.56%.
Does TGTX pay a dividend?
TG Therapeutics, Inc. does not currently show a dividend yield in our data.
What is the return on equity (ROE) of TGTX?
TG Therapeutics, Inc. has a return on equity (ROE) of about 74.03%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of TGTX?
Over the past 52 weeks, TGTX has traded between a low of $26.76 and a high of $59.30.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.